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Abstract
The rich diversity of marine macroalgae and their associated bacterial flora represent a potential reservoir of bioactive 
compounds with valuable biotechnological and pharmaceutical use. Heterotrophic bacteria associated with the intertidal 
macroalgae were isolated and evaluated for their pharmacological properties using various in vitro models. Among 148 
cultivable isolates, more than 50% were dominated by γ-Proteobacteria and Firmicutes, wherein 53 of them showed consist-
ent antibacterial activity against a broad spectrum of clinically significant pathogens. The bacteria were characterized by 
extensive microbiological, molecular and chemical identification tools. The heterotrophs Bacillus amyloliquefaciens MTCC 
12716 and Shewanella algae MTCC 12715 isolated from a red marine macroalga Hypnea valentiae exhibited potential 
anti-infective properties against multidrug-resistant pathogens, such as methicillin-resistant Staphylococcus aureus and 
vancomycin-resistant Enterococcus faecalis (minimum inhibitory concentration of 6.25–12.5 µg/mL). The organic extract 
of B. amyloliquefaciens displayed significantly greater antioxidative properties  (IC90 < 1 mg/mL) and the activities showed 
considerable positive correlation (r2 > 0.8, P < 0.05) with the inhibitory activities against angiotensin converting enzyme-I, 
pro-inflammatory cyclooxygenases and 5-lipoxygenase, dipeptidyl peptidase-4 and hydroxymethylglutaryl coenzyme A 
reductase, which were associated with hypertension, inflammation, diabetes, and hypercholesterolemia, respectively. The 
applications of nuclear magnetic resonance-based fingerprinting to analyze the characteristic signals in the solvent extracts 
and to correlate them with the pharmaceutical properties were underlined. The heterotrophic bacterium B. amyloliquefaciens 
MTCC 12716 might, therefore, serve as a potential therapeutic candidate to develop products with wide pharmaceutical 
applications.
Keyword Intertidal marine macroalgae · Heterotrophic bacteria · Firmicutes · Bacillus amyloliquefaciens MTCC 12716 · 
Antibacterial · Pharmacological properties · Nuclear magnetic resonance-based fingerprinting
Introduction
Marine microbial heterotrophic symbionts were recognized 
for their capacity in imparting biochemical defences to the 
host eukaryotes to fight with competitive predators and path-
ogenic colonizers (Paul et al. 2011). These symbionts were 
reported to be endowed with potential bioactivities against 
pathogenic bacteria, inflammation, and cancer, to mention a 
few, and therefore, are valuable resources for drug discovery 
(Molinski et al. 2009). Recent research efforts established 
that, most often, the microbial symbionts are the sources of 
bioactivities associated with the host-eukaryotic symbiotic 
association, and apparently not the eukaryotic hosts (Li and 
Vederas 2009).
The fraction of bioactive bacteria in association with 
invertebrates (20%) and marine macroalgae (11%) was 
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described to be greater than those isolated from the surface 
seawater (more than 6%) and sediments (~ 5%) (Li and Ved-
eras 2009) although lesser than 5% of them were cultivable 
under laboratory conditions. This directed to the conclusion 
that marine microbes have been uncultivable, and therefore, 
received meager attention to the scientists. However, recent 
research efforts proved that selected marine microorganisms 
could be cultivated successfully (Davidson 1995). Bacterial 
and fungal association were reported from the internal tissues 
of invertebrates and marine plant surfaces, whereas the sym-
bionts harbored promising pharmaceutical properties (Web-
ster and Taylor 2012). Bacterial groups, such as Firmicutes, 
Bacteroidetes and γ-Proteobacteria were predominantly pre-
sent in association with marine macroalga Laminaria sac-
charina (Wiese et al. 2009). Among these, γ-Proteobacteria 
was found to be the predominant cultivable class in the Hal-
iclona simulans sponge-associated heterotrophs (Kennedy 
et al. 2009) and marine macroalga Jania rubens associated 
(greater than 70%) microbes (Ali et al. 2012). As a sessile 
primary producer, marine macroalgae were reported to host 
wide varieties of microbes on its surface compared to other 
marine eukaryotes (Hollants et al. 2012). The compara-
tive simplicity of culturing these bacteria, equated to other 
microbes that release bioactive metabolites, suggested that 
the macroalgae-associated bacteria might be useful in bio-
technological applications, especially as the potential source 
of antimicrobial agents (Armstrong et al. 2001).
Microorganisms were recognized as valuable biologi-
cal resources of chemically as well as biologically diverse 
compounds, whereas their potential capabilities to biosyn-
thesize complex chemical entities from common nutrients 
in fermentation media have made them promising for the 
extensive use in the production of pharmaceutical prepa-
rations. More than 120 formulations of microbial origin 
are currently in clinical use for the treatment of cancer and 
infectious diseases, and as immune suppressors to aid organ 
transplantation (National Research Council 1999). They 
have also been demonstrated to possess varied properties 
of potential therapeutic applications, such as antioxidant 
(Tabbene et al. 2012), anti-diabetic adjuvant (Okamura et al. 
1992), anti-inflammatory formulations (Tang et al. 2010), 
etc. Among different phyla of marine bacteria, Firmicutes 
and γ-Proteobacteria were recognized as important sources 
of bioactivities with potential pharmacological significance 
(Lachnit et al. 2011; Thilakan et al. 2016).
Earlier reports on macroalgae-associated bacteria con-
templated their potential as antibacterial pharmacoph-
ores for use against human pathogenic microorganisms 
(Chakraborty et al. 2017a, b). As an ongoing programme 
to isolate and characterize marine macroalgae-associated 
symbionts, the present work has been directed to a culture-
dependent method to isolate heterotrophic Firmicutes and 
γ-Proteobacteria associated with the intertidal marine 
macroalgae, and evaluate for their pharmacological proper-
ties using various in vitro models. The bacteria were charac-
terized by extensive microbiological, biotechnological and 
chemical identification tools. Based on the anti-infective 
potential against clinically significant pathogens, the het-
erotrophic B. amyloliquefaciens MTCC 12716 and S. algae 
MTCC 12715 were used to prepare organic extracts, and 
that were assayed for their antioxidant potential along with 
their abilities to inhibit various pharmacological targets, 
such as angiotensin converting inhibitory enzyme-1 (ACE-
1), pro-inflammatory cyclooxygenases and lipoxygenase 
(COX-1, 2 and 5-LOX), dipeptidyl peptidase-4 (DPP-4) and 
hydroxymethyl glutaryl coenzyme A reductase (hMGCR) 
associated with hypertension, inflammation, diabetes and 
hypercholesterolemia, respectively. The 1H NMR and 13C 
NMR-based chemical fingerprint analyses of the prominent 
functionalities in the organic extracts of the heterotrophs 
were determined to underline the significance of electron-
rich unsaturated centers towards the bioactive properties.
Materials and methods
Isolation of marine macroalgae‑associated 
heterotrophs
The marine macroalgae referred to the classes of Rhodo-
phyceae, Phaeophyceae and Chlorophyceae, were collected 
from the intertidal zone by hand, at low tide. The samples 
were collected from the coastal area of Mandapam situ-
ated at 9°17′0″ North, 79°7′0″ East, Gulf of Mannar region 
and Vizhinjam harbor located at 8.3932° North, 77.0046° 
East, in the Arabian Sea, at the Southern Coast of Peninsu-
lar India. The macroalgal samples were placed in a sterile 
polythene bag filled with seawater and were kept in the dark 
at 4 °C until further processing in the laboratory. Symbiotic 
heterotrophic bacteria associated with the marine macroalga 
Hypnea valentiae were isolated and purified by following 
previous reports of literature (Quevrain et al. 2014; Thilakan 
et al. 2016).
Briefly, the specimen samples (10 g) were thoroughly 
washed in sterile distilled water to remove loosely attached 
microbes and filth. Further, they were suspended in ster-
ile seawater (10 mL) and homogenized using a pestle and 
mortar in a laminar airflow hood under an aseptic condi-
tion. The suspension was serially diluted in sterile seawater 
(9 mL), and different dilutions were plated on the isolation 
medium of Zobell Marine Agar, which was supplemented 
with sodium chloride (NaCl, 1% w/v). The incubation was 
performed in the dark at 30 °C for 7 days. The pure colonies 
were obtained by subsequent isolation and purification steps 
on Zobell Marine Agar medium supplemented with NaCl 
(1% w/v) (Wiese et al. 2009; Chakraborty et al. 2014). Streak 
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plate method was used to isolate an axenic culture. The bac-
teria isolated were then classified based on morphology and 
identified with biochemical tests, 16S rRNA fingerprinting 
followed by MALDI-TOF biotyping as discussed in the fol-
lowing section. The growth and bioactivity of the strains 
used in this study were optimized under various nutritional 
parameters, whereas an optimized media (modified basal 
salt agar) was used for the biomass production based on 
the study. The isolates were subjected to primary screening 
for their antibacterial potentials. The producer strains were 
maintained in the same media at 20 °C and found to be con-
sistently active. Further, the most active strains were selected 
and their soluble secondary metabolites were extracted and 
bioactivities were analyzed against different disease models.
Primary antibacterial screening for active strains
Antibacterial properties of the heterotrophic isolates was 
examined by spot on the lawn assay (Chakraborty et al. 
2014). In brief, a lawn of the pathogenic bacteria was made to 
grow on Mueller–Hinton agar plates, over which the isolates 
at its late log phase were spotted in an aseptic condition. The 
test pathogenic organisms, such as Escherichia coli (MTCC 
443), Streptococcus pyogenes (MTCC 1924), and Edwards-
iella tarda (MTCC 2400) were obtained from the National 
Centre for Aquatic Animal Health-(NCAAH) of Cochin Uni-
versity of Science and Technology (CUSAT), Cochin. Patho-
genic Vibrio parahaemolyticus (MTCC 451) was obtained 
from the Microbial Type Culture Collection and Gene Bank 
(MTCC) of Institute of Microbial Technology (Chandigarh, 
India), an affiliate member of the World Federation for Cul-
ture Collections (WFCC) and recognized as an International 
Depository Authority (IDA). These cultures were maintained 
in our laboratory, and multidrug-resistant pathogens includ-
ing methicillin-resistant Staphylococcus aureus (ATCC 
33592) and vancomycin-resistant Enterococcus faecalis 
(ATCC 51299) were procured from the American Type Cul-
ture Collection (Manassas, VA, USA). The pathogens were 
procured during the period of 2016, and their pathogenicities 
were assessed by performing PCR amplification with specific 
virulent factors for each pathogenic bacterium, immediately 
after obtaining the cultures. Their identities were confirmed 
by specific phenotypic and genotypic characterization, such 
as microbiological and biochemical testing, followed by 16S 
rRNA sequence similarity check (Armstrong et al. 2001). 
The pathogenic strains were maintained in Brain heart infu-
sion agar and Nutrient agar supplemented with NaCl as per 
manufacturers’ protocol.
The antibacterial activities were recorded according to 
the inhibition zone developed on the plates after a period 
of 48-h incubation at 30 °C. Further, the crude extracts 
of selected strains were assessed by Minimum Inhibi-
tory Concentration (MIC) by broth microdilution assay 
according to the National Committee for Clinical Labora-
tory Standards (NCCLS, 2004) with minor modifications. 
The MIC was determined by means of serial dilutions of 
the extracts (Balouiri et al. 2016) and positive control 
(chloramphenicol). The test samples of 100 µL were seri-
ally diluted in multi-well assay plates, whereas the patho-
genic bacterial broth (100 µL, 2 × 106 cell/mL) was added 
separately. The plate was then incubated for 24 h at 37 °C, 
and the minimum concentration of the sample, which 
inhibit the growth of the pathogen, where the  OD600 of 
the well was near to or equal to zero, has been considered 
as the MIC. Further, the bactericidal property of the sam-
ples was affirmed by observing the plates after the addi-
tion of tetrazolium salt of 3-(4, 5-dimethylthiazol-2-yl)-2, 
5-diphenyltetrazolium bromide (MTT) to the wells.
Identification of the active isolates
The antagonistic bacteria were identified phenotypically, 
supported by the biochemical methods (Krieg and Holt 
1984), Matrix Assisted Laser Desorption/Ionization-Time 
of Flight Mass Spectrometry (MALDI-TOF MS), fol-
lowed by 16S rRNA sequencing (Armstrong et al. 2001) 
and analysis of bacterial membrane fatty acid (Zhu et al. 
2005). Mass spectroscopic experiments were performed 
on a MALDI-TOF MS spectrometer (Microflex, BrukerD-
altonics, Germany) operating in a linear positive mode. 
Mass spectra were evaluated between the m/z range of 
2000 to 20,000, and analyzed by the MALDI Biotyper 
(version 3.1) for strain identification. Briefly, the bacterial 
proteins were extracted with ethanol/formic acid extrac-
tion method, whereas 1 µL of the extract was spotted on 
the target plate, and allowed to dry before being covered 
with 1 µL of α-cyano-4-hydroxycinnamic acid. The cut-
off score for similarity search was ≥ 1.7 for species-level, 
and any score lesser than this was considered as an unre-
liable identification. The isolates showing significant 
inhibitory activity were selected and phenol–chloroform 
extraction method was adopted for isolating DNA from the 
active strains. Further, the qualities of DNA samples were 
detected by agarose gel electrophoresis and their concen-
trations were evaluated using a Biophotometer (Applied 
Biosystems, USA). Universal primers AGA GTT TGA TCC 
TGG CTC AG (forward) and ACG GCT ACC TTG TTA CGA 
CTT (reverse) (Weisburg et al. 1991) were employed to 
amplify the 16S rRNA gene. Further, the PCR products 
were sequenced and deposited in the NCBI GenBank.
Assessment of pathogenicity
Pathogenicity of the selected microorganisms was studied 
by hemolytic assay (Gao et al. 2000) on sheep blood agar 
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plates. Briefly, blood agar with 5% defibrinated sheep blood 
was dispensed into a sterile Petri-plate aseptically. Over-
night grown cultures of the bacteria were spot inoculated at 
the center of the plates and incubated at 30 °C for 18–24 h. 
Streptococcus pyogenes MTCC 1924 was used as the control 
organism.
Preparation of crude extracts and in vitro bioassays
The extracellular metabolites of the potentially antago-
nistic bacteria B. amyloliquefaciens (MTCC 12716) and 
S. algae (MTCC 12715) were extracted with a suitable 
organic solvent. In brief, the bacteria were surface cultured 
over nutrient agar in the dark at 30 °C for 72 h in the case 
of S. algae, and 48 h for B. amyloliquefaciens. After the 
incubation period, the culture on the surface was removed, 
and the agar with the extracellular metabolites was exhaus-
tively extracted by refluxing with solvent ethyl acetate on 
a temperature-controlled water bath before being concen-
trated in vacuo on a rotary vacuum evaporator (Heidolph, 
Schwabach, Germany). The ethyl acetate extract (470 g) 
of the antagonistic bacteria were assayed in vitro for their 
antioxidant potential along with their abilities to inhibit 
various pharmacological disease targets, such as angio-
tensin converting enzyme-1 (ACE-1), pro-inflammatory 
cyclooxygenases and lipoxygenase (COX-1, 2 and 5-LOX), 
dipeptidyl peptidase-4 (DPP-4), and hydroxymethyl glutaryl 
coenzyme A reductase (hMGCR) associated with hyper-
tension, inflammation, diabetes and hypercholesterolemia, 
respectively.
Antioxidant activity
Antioxidant activities of the crude extracts were evaluated 
by 1, 1-diphenyl-2-picrylhydrazyl (DPPH) and 2, 2-azino-
bis (3-ethyl-benzothiazoline-6-sulfonic acid) (ABTS) free 
radical scavenging abilities. The measurement of DPPH 
radical scavenging activity was performed by a previously 
described method (Brand-Williams et al. 1995). The changes 
in color were read at an absorbance of 517 nm after 20 min 
of reaction by a UV–VIS spectrophotometer (Varian Cary, 
USA).  ABTS+ assay was carried out by an established 
method of Re et al. (1999). The reaction mix was kept for 
6 min, and the absorbance was recorded at 734 nm. DPPH/
ABTS scavenging activities (in percentage) were expressed 
as (AC – AS)/AC × 100, where  AC represented the absorb-
ance of control and  AS that of the sample. The scavenging 
activities on DPPH/ABTS+ radical were documented, and 
the  IC90 values (concentration of the bacterial crude extracts 
that inhibit 90% of the radical/enzyme, mg/mL) calculated 
using the non-linear regression plot. Ascorbic acid was used 
as the standard during the assessment of free radical scav-
enging activity.
Anti‑hypertensive activity
Anti-hypertensive activities of the extracts were assessed 
based on the inhibition rate of ACE-1 (Holmquist et al. 
1979). In brief, ACE-1 (20 µL, 1 U/mL, from rabbit lung) 
was mixed with the crude extracts (100 µg), and the mixture 
was added with N-[3-(2-furyl) acryloyl]-l-phenylalanylgly-
cylglycine (FAPGG, 0.5 mM) dissolved Tris–HCl buffer 
(pH 7.5) supplemented with common salt. The reduction 
in absorbance at 345 nm was monitored with a multi-plate 
reader (Multiskan GO type 1510, Thermo Scientific, USA) 
within a 1.5 min interval at room temperature, and was 
stated as ΔAbsample/min. Blank was set with distilled water 
and expressed as ΔAb blank/min. Captopril was served as 
the positive control for ACE inhibition. The plots of ACE-1 
inhibition by the extracts were recorded, and the  IC90 values 
(mg/mL) were calculated.
Anti‑diabetic activity
The crude extracts were assayed for their anti-diabetic activi-
ties by inhibition of α-glucosidase, α-amylase, and DPP-4 
(dipeptidyl peptidase-4) enzymes. The α-amylase and 
α-glucosidase inhibitory activities of the studied extracts 
were measured by the standard method (Ademiluyi and 
Oboh 2013) with suitable alteration. The absorbance of the 
reaction mixture was measured at 540 and 405 nm, respec-
tively, whereas acarbose was used as a standard. For the 
inhibition of DPP-4, the extracts were made in different 
strengths in Tris–HCl buffer (0.05 M, pH 7.5). The substrate 
(gly-pro-p-nitroanilide) was added to the reaction mixture 
before an incubation period of 30 min at 37 °C. Glacial ace-
tic acid (25%) was added to quench the reaction, and the 
absorbance was recorded at 450 nm, whereas diprotein-A 
(Ile-Pro-Ile) was used as a reference.
Anti‑inflammatory and anti‑hypercholesterolemic 
activities
Dual blocking of both cyclooxygenases (COX-1 and COX-2) 
and 5-lipoxygenase (5-LOX) is a commonly used method 
for the treatment of inflammatory diseases without causing 
severe side effects (Charlier and Michaux 2003). The in vitro 
COX (Larsen et al. 1996) and 5-LOX inhibition assays (Bay-
lac and Racine 2003) were used to determine the anti-inflam-
matory activities of the bacterial extracts. The 3-hydroxy-
3-methyl-glutaryl-coenzyme A (hMG-CoA) reductase 
enzyme inhibition by crude B. amyloliquefaciens and S. 
algae extracts was evaluated with hMG-CoA reductase 
(hMGCR) assay kit from Sigma-Aldrich (St. Louis, MO, 
USA) to assess their anti-hypercholesterolemic activities. In 
brief, the crude organic extracts were added with the reac-
tion mixture containing nicotinamide adenine dinucleotide 
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phosphate (0.4 mM) and hMG-CoA (0.4 mM) in a final vol-
ume of 0.2 mL of potassium phosphate buffer (0.1 M, pH 
7.4) containing KCl (0.12 M), ethylenediaminetetraacetic 
acid (1 mM), and dithiothreitol (5 mM), before being added 
with HMG-CoA reductase (human recombinant, 2 µL) and 
incubated at 37 °C in the multi-plate reader spectroscopic 
instrument (Multiskan GO, Thermo Scientific, USA) fitted 
out with thermostatically organized cell holder. The rates of 
NADPH consumption were monitored every 20 s for up to 
15 min by spectral scanning at 340 nm. Percentage inhibition 
of COX-1, COX-2, 5-LOX and hMGCR were calculated, 
and the results were expressed in  IC90, the concentration at 
which it inhibits 90% of the enzyme activity.
Spectroscopic fingerprint analyses
Spectroscopic fingerprint characteristics of the organic 
extracts were comprehensively studied by Fourier transform 
infrared spectrometer (Perkin-Elmer Series 400 FTIR, USA) 
scanned between wave-numbers 4000–400 cm−1 and nuclear 
magnetic resonance (13C NMR and 1H NMR) spectral analy-
sis on a Bruker AVANCE III 600 MHz spectrometer (Bruker, 
Germany). Chemical shift (δH or δC) values were recorded 
as ppm (δ, parts per million), and the protons at the definite 
regions of the 1H NMR spectra were integrated (proton inte-
gral, ΣH) to determine the aggregate number of protons in 
characteristic regions of the spectra (Fig. 2). The 1H-NMR 
spectra were allocated into five discrete regions, such as 
alkane hydrocarbon (primary through tertiary, δH 0.1–2.0), 
allylic  (CH2=CH–Me)/acetyl {–C(=O)Me}/derivatized 
hydride of alkanoates {–CH2C(=O)O–, δH 2.1–2.5}, meth-
oxyl (–OMe)/functionalized alkanol (–CH2OH, δH 2.6–3.5), 
anomeric (due to polysaccharides, δH 3.6–4.5), olefinic 
(–CH=CH–)/protons of the hydride group of alkanoates 
{–CH2C(=O)OMe, δH 4.6–6.0}, and aryl protons  (C6H5–H, 
δH 6.6–8.6) (Table 1). The 1H NMR trace at δH 9–10 char-
acterized the aldehydic protons. The 13C NMR spectral 
data were used to recognize the carbons attributed to alkane 
hydrocarbon (δC up to 40), alkoxy (–CH2O–; δC 45–70), car-
bons of the hydride group of alkanoates {–CH2C(=O)OMe, 
δC 75–80), functionalized olefine (δC 110–140), aromatic (δC 
140–160), ester alkanoates {–C (=O)O–; δC 160–180} and 
carbonyl (aldehydic/ketonic) moieties (δC 180–210).
Statistical analysis
Statistical analysis was carried out using the SPSS software 
(SPSS Inc, USA, ver. 10.0). The studies were carried out in 
triplicate, and the means were determined for significance at 
5 percent level (P < 0.05) by means of analysis of variance 
(ANOVA). The mean variances in the data set were identi-
fied with principal component analysis (PCA).
Results
Isolation of marine macroalgae‑associated 
heterotrophs and antibacterial screening
Seven different intertidal macroalgae representing Rhodo-
phyceae, Phaeophyceae and Chlorophyceae were collected 
from the intertidal zones, and that include brown algae, 
Sargassum myricocystum, Padina gymnospora, Turbinaria 
ornata, red algae Hypnea valentiae. Kappaphycus alvarezii 
and green algae Ulva reticulata, Caulerpa racemosa. A total 
number of 148 heterotrophic bacterial strains were isolated 
from the macroalgal species. The bacteria isolated were clas-
sified based on morphology and further with microbiological 
and biochemical tests, 16S rRNA fingerprinting followed by 
MALDI-TOF biotyping.
The bacterial classes of Gamma proteobacteria and Fir-
micutes represented the predominant bacterial communities 
comprising more than 50% of the total isolates screened. 
The isolated bacteria were further screened for their anti-
bacterial activity by spot over lawn assay, and 53 of them 
showed consistent antibacterial activity against at least 
Table 1  Nature and integral 
values of protons obtained from 
the 1H-NMR of the organic 
extracts of B. amyloliquefaciens 
MTCC 12716 and S. algae 
MTCC 12715
a The protons at the defined regions of the 1H NMR spectra were integrated to get the number of protons in 
specific regions
Integral values of protons
Type of  protonsa Chemical shift (δ) S. algae MTCC 
12715
B. amylolique-
faciens MTCC 
12716
Saturated hydrocarbons 0.5–2.0 329.7 152.9
–CH2=CH–CH3/RC(=O)CH3/
RCH2C(=O)OR1/Ar-CH3
2.1–2.5 61.81 40.73
–OCH3/RCH2–X/RCH2OH 2.6–3.5 23.94 22.96
Anomeric (due to polysaccharides) 3.6–4.5 48.02 64.73
RCH=CHR1/RCH2C(=O)OCH3 4.6–6.0 18.82 12.42
Ar-H 6.6–8.6 25.80 28.77
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one test pathogen. Bactericidal activities were furthermore 
ascertained by MTT reaction, whereas the blue cells were 
indicated as live. The antibacterial activities of these hetero-
trophs against the pathogens were summarized in Table 2. 
Two of the most active cultures B. amyloliquefaciens and S. 
algae (Fig. 1), which were isolated from Hypnea valentiae 
were selected to study their pharmacological properties in 
greater details based on their superior bioactivity among 
other strains. The growth and bioactivities of the strains 
used in this study were optimized under various nutritional 
parameters, whereas an optimized media (modified basal 
salt agar) was used for the biomass production based on the 
study. The producer strains were maintained in the same 
media at 20 °C, and found to be consistently active under 
laboratory culture condition.
These isolates were characterized by biochemical, mem-
brane analysis of fatty acids, 16S rRNA gene sequencing, 
followed by MALDI-TOF MS with a confidence score 
of 1.953 and 2.152 as B. amyloliquefaciens and S. algae, 
respectively. Among the selected bacterial strains, B. 
amyloliquefaciens belonged to Gram-positive, and S. algae 
was classified as Gram-negative, as determined by Gram 
staining and potassium hydroxide (KOH) screening experi-
ments. Biochemical experiments deduced S. algae as rod-
shaped, aerobic, and brown pigmented bacterium, which was 
able to ferment sugars to produce hydrogen sulfide on triple 
iron sugar (TSI) slants, whereas B. amyloliquefaciens, with 
the morphology of being white wavy, lobed margins, pos-
sessed casein hydrolysis and nitrate reduction properties. 
Blackish-brown pigmentation by S. algae was recorded at 
the late exponential phase due to the production of pyomela-
nin (Turick et al. 2008). Optimal growth of S. algae occurred 
with pH 8.0 in the presence of 1–4% of NaCl at tempera-
ture 30 °C, and B. amyloliquefaciens at 37 °C with pH 7–9. 
The predominance of terminally methyl-branched iso and 
anteiso fatty acids with C−12 to 17 characterized S. algae, 
whereas  C15 and  C17 iso/anteiso fatty acids were predomi-
nant in B. amyloliquefaciens. Among the n-9 fatty acids, 
cis-octadec-9-enoate (C18:1n-9c) was found to be present in 
S. algae other than cis-octadec-11-enoate (C18:1n-7c) and 
cis-heptadec-11-enoate (C17:1n-6c). Further, the similarity 
of 16S rRNA sequences was tested with known sequences 
of B. amyloliquefaciens and S. algae using BLAST search 
tool, and submitted in GenBank with accession numbers of 
KX272634 and KX272635, respectively. These bioactive 
isolates were deposited in Microbial Type Culture Collection 
(MTCC), an International microbial depository authority in 
South-East Asia under the Budapest Treaty, with accession 
numbers of B. amyloliquefaciens MTCC 12716 and S. algae 
MTCC 12715, respectively.
The crude organic (ethyl acetate) extracts of B. 
amyloliquefaciens MTCC 12716 and S. algae MTCC 12715 
exhibited strong antagonism against a broad spectrum of 
pathogenic bacteria, Escherichia coli (gastrointestinal infec-
tion), Streptococcus pyogenes (skin infection), Edwardsiella 
tarda (gastrointestinal infection and myonecrosis), Vibrio 
parahemolyticus (gastrointestinal infection), MRSA (methi-
cillin-resistant Staphylococcus aureus) (skin infection) and 
VRE (vancomycin-resistant Enterococcus faecalis) (sepsis 
and meningitis) (Fig. 1). Inhibitory activities of the bacte-
rial isolates were observed on MTT-sprayed Mueller Hin-
ton agar plates. The microdilution method also displayed a 
significant MIC of 6.25–25 µg/mL against the test patho-
genic bacteria (Table 2). Additionally, there was no zone 
Table 2  Antibacterial activities of marine macroalgae-associated heterotrophic B. amyloliquefaciens MTCC 12716 and S. algae MTCC 12715 
against pathogenic bacteria and minimum inhibitory concentrations (MICs) of their ethyl acetate extracts
Data were expressed as mean ± standard deviation of three replicates. Means followed by the different superscripts (a–c) within the same row 
indicate significant difference (P < 0.05)
a Inhibition zone diameter (in mm)
b Minimum Inhibitory concentration (µg/mL) of ethyl acetate extract of the bacteria
c Standard antibiotic (positive control)
Test pathogens B. amyloliquefaciens MTCC 12716 S. algae MTCC 12715
Inhibition  zonea (mm) Crudeb MIC 
(µg/mL)
Inhibition  zonea (mm) Crdeb 
(MIC) (µg/
mL)
Vibrio parahaemolyticus (MTCC 451) 32a ± 0.60 6.25 27a ± 0.07 12.5
Methicillin resistant Staphylococcus aureus (ATCC 33592) 22a ± 0.60 12.5 16b ± 0.04 12.5
Vancomycin resistant Enterococcus faecalis (ATCC 51299) 20b ± 0.37 6.25 14b ± 0.03 12.5
Escherichia coli (MTCC 443) 10c ± 0.25 12.5 11c ± 0.05 25.0
Edwardsiella tarda (MTCC 2400) 21a ± 0.30 6.25 17b ± 0.02 6.25
Streptococcus pyogenes (MTCC 1924) 10c ± 0.44 6.25 11b ± 0.09 12.5
Chloramphenicolc 27a ± 0.30 6.25 27a ± 0.30 6.25
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of clearance indicating hemolytic activity developed on the 
blood agar plates with the test organisms B. amyloliquefa-
ciens MTCC 12716 and S. algae MTCC 12715, whereas 
S. pyogenes exhibited complete hemolysis (β-hemolysis) 
around the colonies.
Pharmacological activities of the extracts of B. 
amyloliquefaciens MTCC 12716 and S. algae MTCC 
12715
The solvent extracts of B. amyloliquefaciens MTCC 12716 
and S. algae MTCC 12715 were assayed in vitro for their 
antioxidant potential along with their abilities to inhibit var-
ious pharmacological targets, such as ACE-1, pro-inflam-
matory enzymes (COX-1, 2, 5-LOX), DPP-4 and hMGCR, 
which were associated with hypertension, inflammation, 
diabetes and hypercholesterolemia, respectively. The organic 
extract of B. amyloliquefaciens MTCC 12716 exhibited sig-
nificantly greater antioxidative potential as determined by the 
scavenging activities of DPPH  (IC90 278 µg/mL) and  ABTS+ 
 (IC90 136 µg/mL) radicals compared to that obtained from S. 
algae MTCC 12715  (IC90 602 and 483 µg/mL, respectively). 
The ethyl acetate extract derived from B. amyloliquefaciens 
MTCC 12716 exhibited significantly greater inhibition 
towards ACE-1  (IC90 448  µg/mL) than that of S. algae 
MTCC 12715  (IC90 638 µg/mL) (P < 0.05). Likewise, the 
organic extracts of B. amyloliquefaciens MTCC 12716 and 
S. algae MTCC 12715 were found to inhibit α-amylase and 
DPP-4 with  IC90 639–837 and 354–769 µg/mL, respectively. 
Notably, the α-glucosidase inhibitory potential of the organic 
extract from B. amyloliquefaciens MTCC 12716  (IC90 84 µg/
mL) and that of S. algae MTCC 12715  (IC90 530 µg/mL) 
were significantly greater than the standard Acarbose  (IC90 
645 µg/mL). The extracts exhibited considerable inhibition 
against the pro-inflammatory enzymes, which appeared to 
play significant functional roles in the metabolic pathway 
of inflammation. The organic extract from B. amyloliquefa-
ciens MTCC 12716 and S. algae MTCC 12715 were found 
to be selective COX-2 and 5-LOX inhibitors (anti-COX-2 
 IC90 29–44 µg/mL; anti-LOX-5  IC90 6.06–7.74 µg/mL) than 
commercially available NSAID (aspirin anti-COX-2  IC90 
83–86 µg/mL; anti-LOX–5  IC90 79 µg/mL). A dose-response 
in vitro analysis with regard to the inhibition of hMGCR 
displayed significant activity with the ethyl acetate extract of 
B. amyloliquefaciens MTCC 12716  (IC90 17.3 µg/mL) and S. 
algae MTCC 12715  (IC90 74.6 µg/mL) (Table 3).
Fig. 1  a Spot over lawn assay 
of the cultures B. amyloliquefa-
ciens MTCC 12716 (BA) and 
S. algae MTCC 12715 (SA) 
against methicillin-resistant 
Staphylococcus aureus (ATCC 
33592). The clear zones dis-
played by the isolates indicated 
the antibacterial activity. Antag-
onistic activities of the isolates 
were recorded as the inhibition 
zone diameter determined as 
a space of ≥ 1 mm between 
the circular area (= lawn of 
the isolate) and the end of the 
clear zone bounded by the 
lawn of the test strain. b View 
of the Gram stained culture of 
B. amyloliquefaciens MTCC 
12716. c Gram stained image of 
S. algae MTCC 12715. d Disc 
diffusion assay with the organic 
extracts of B. amyloliquefaciens 
MTCC 12716 (BA) and S. algae 
MTCC 12715 (SA) against 
VRE (vancomycin-resistant 
Enterococcus faecalis ATCC 
51299), and e MRSA (methi-
cillin-resistant Staphylococcus 
aureus ATCC 33592). The 
zones of antibacterial activities 
were denoted by the arrows
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Spectroscopic fingerprinting of the functional 
groups
The labelling of carbons and protons allied with their char-
acteristic magnetic fields of the functional groups in the 
ethyl acetate extracts of B. amyloliquefaciens MTCC 12716 
and S. algae MTCC 12715 were recorded by the combined 
1H NMR (Fig. 2, Fig. S1-S2) and 13C NMR experiments 
(Fig. 3, Fig. S3-S4). Aromatic proton signals (δH 6.6–8.6) 
were recorded in the 1H NMR spectral data of the bacterial 
extracts, whereas that extracted from B. amyloliquefaciens 
MTCC 12716 displayed the greater proton integral (∑H) of 
about 28.77 than that recorded with S. algae MTCC 12715 
extract (∑H 25.80). Higher proton integrals (∑H 23.94) 
at δH 2.5–3.5 (attributed to the presence of -OCH3/RCH2-
X/RCH2OH groups) were documented in the ethyl acetate 
extract of S. algae MTCC 12715. The number of protons 
at δH 2–2.5 were attributed to the acetyl or allylic function-
alities, and were recorded to be higher in S. algae MTCC 
12715 (∑H 61.81), whereas comparatively weaker proton 
integrals at this position were noted for B. amyloliquefa-
ciens MTCC 12716 extract (∑H 40.73). Notably, the proton 
integrals at the olefinic region (δH 4.5–6) of organic extract 
derived from S. algae MTCC 12715 was marginally higher 
(∑H 18.82) than that recorded with B. amyloliquefaciens 
MTCC 12716 extract (∑H 12.42). The ethyl acetate extract 
of S. algae MTCC 12715 displayed greater proton inte-
gral owing to saturated hydrocarbons, whereas that of B. 
amyloliquefaciens MTCC 12716 exhibited greater signals 
in the downfield (with a predominance of electronegative 
functional groups) region of the NMR spectrum. It is inter-
esting to note the greater proton integrals at δH 3.6–4.5 (∑H 
64.73, due to anomeric protons associated with polysaccha-
rides) of organic extract due to B. amyloliquefaciens MTCC 
12716, whereas comparatively weaker proton integrals at 
this position were noted for S. algae MTCC 12715 extract 
(∑H 48.02).
The attributions of different types of carbons (pri-
mary through quaternary) in the EtOAc extracts of the 
heterotrophic bacteria were furthermore confirmed by 
extensive 13C NMR experiments. The EtOAc extract of 
S. algae MTCC 12715 exhibited a greater number of car-
bon atoms assigned to the saturated hydrocarbons (δC 
10–40) (Fig. 3), and the results were in accordance with 
the greater proton integrals of the same (∑H 329.7). Like-
wise, a greater number of aromatic signals (δC 140–160) 
was recognized in the EtOAc extract of B. amylolique-
faciens MTCC 12716 than that displayed by S. algae 
MTCC 12715. The distinctive peaks attributed to the car-
bonyl groups were recorded at δC 180–200, which were 
abundant in the organic extract of B. amyloliquefaciens 
MTCC 12716, whereas meager traces of these highly 
Table 3  Pharmacological 
properties of the organic 
extracts of B. amyloliquefaciens 
MTCC 12716 and S. algae 
MTCC 12715 by various 
in vitro models
The samples were analyzed in triplicates (n = 3) and expressed as mean ± standard deviation. Means fol-
lowed by the different superscripts (a–c) within the same row indicate significant difference (p < 0.05)
Other notations were as described in the text
a The standard antioxidant agent was α-tocopherol, whereas aspirin and acarbose were used as standard 
anti-inflammatory and anti-diabetic agent. Synthetic captopril and atorvastatin were used as standard ACE 
and hMGCR inhibitors, respectively
Activities  IC90 (µg/mL)
Pharmacological properties Standarda B. amyloliquefaciens 
MTCC 12716
S. algae MTCC 12715
Antioxidant activities
 DPPH radical scavenging 76.01a ± 0.03 278.19b ± 0.04 602.83c ± 0.06
 ABTSa radical scavenging 30.76a ± 0.01 136.78b ± 0.01 483.02c ± 0.09
Anti-inflammatory activities
 COX-1 inhibitory activity 91.30a ± 0.09 675.36b ± 0.04 557.48b ± 0.04
 COX-2 inhibitory activity 86.93a ± 0.07 29.10b ± 0.07 44.00c ± 0.04
 5-LOX inhibitory activity 79.68a ± 0.02 6.06b ± 0.02 7.73c ± 0.08
Anti-diabetic activities
 α-amylase inhibitory activity 312.44a ± 0.01 639.54b ± 0.05 837.69c ± 0.03
 α-glucosidase inhibitory activity 645.08a ± 0.05 84.00b ± 0.01 530.43c ± 0.07
 DPP-4 inhibitory activity 7.00a ± 0.03 354.12b ± 0.02 769.63c ± 0.09
Anti-hypertensive activity
 ACE inhibitory activity 77.39a ± 0.01 448.57b ± 0.05 638.74c ± 0.03
Anti-hypercholesterolemic activity
 hMGCR inhibitory activity 0.07a ± 0.06 17.30b ± 0.01 74.60b ± 0.01
Author's personal copy
513Archives of Microbiology (2019) 201:505–518 
1 3
Fig. 2  The stacked plot representing the 1H NMR spectra of EtOAc extracts of (A) B. amyloliquefaciens MTCC 12716 and (B) S. algae MTCC 
12715
Fig. 3  13C NMR spectra of organic extracts of (A) B. amyloliquefaciens MTCC 12716 and (B) S. algae MTCC 12715. The chemical shift (δ) 
values were expressed in parts per million (ppm), and were referenced to the residual solvent signals of  CDCl3
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electronegative groups were apparent in that obtained 
from S. algae MTCC 12715 (Fig. 3). The 13C olefinic 
carbon traces at δC 110–140 were displayed by the EtOAc 
extract of B. amyloliquefaciens MTCC 12716 and S. algae 
MTCC 12715, although lesser proton integrals were 
recorded in the 1H NMR spectrum of the former, which 
might be attributed to the occurrences of quaternary 
olefinic carbons in the organic extract of B. amyloliquefa-
ciens. The 13C NMR signals due to the alkoxy (–CH2O–; 
δC 45–70) group and those associated with the carbons 
of the hydride group of alkanoates {–CH2C(=O)OMe, δC 
75–80} were found to be greater in the EtOAc extract of 
S. algae MTCC 12715 than that recorded in the extract 
prepared from B. amyloliquefaciens MTCC 12716.
A sharp FTIR band at 3700  cm− 1 region repre-
sented free O–H stretching in the solvent extracts of B. 
amyloliquefaciens MTCC 12716 and S. algae MTCC 
12715 (Fig. S5-S6). The broad bands in the region of 
3200–3600 cm−1 might represent the hydrogen bonded 
O-H stretching vibration. Intense IR bands at 2928 and 
2963  cm−1 might be related with the occurrences of 
alkyl C-H stretching and a variable frequency at 1667 
and 1662 cm−1 indicated alkenyl C=C stretching and/
or aromatic C=C bending. Variable peaks at 1449 and 
1457  cm−1 were attributed to C-H bending of alkane 
groups.
Principal component analysis
The resemblances and differences between crude extracts 
of the two bacterial species B. amyloliquefaciens MTCC 
12716 and S. algae MTCC 12715 vis-a-vis the relation-
ships among antioxidant activity assays and different 
enzyme inhibitory assays were statistically analyzed via 
PCA (principle component analyses) (Fig. 4). PCA was 
performed to corroborate the antioxidant and enzyme 
inhibitory activities contributing to the pharmaceutical 
potential of the titled marine macroalgae-associated sym-
bionts. The loadings of PC1 and PC2 (first and second 
principal components) were added for 50.63 and 49.37% 
of the variance, respectively (Fig. 4). PC1 was primar-
ily inclined by DPPH scavenging activity of the organic 
extracts of B. amyloliquefaciens MTCC 12716 and S. algae 
MTCC 12715 (BD and SD), COX-1 and α-glucosidase 
inhibitory activities (BC1, SC1 and BGL, SGL), along 
with hMGCR (BHMG and SHMG) and DPP-4 inhibitory 
activities of B. amyloliquefaciens MTCC 12716 (BDPP4), 
ABTS and LOX-5 (SA and SL) activities of S. algae 
MTCC 12715. Whereas, DPP-4 inhibitory activities of S. 
algae MTCC 12715 (SDPP4) and ABTS radical scaveng-
ing activity of B. amyloliquefaciens MTCC 12716 (BA) 
were mostly contributed to PC2.
Discussions
Marine macroalgae were reported to possess chemical 
defense programmes against pathogenic microorganisms in 
oceanic ecosystem, and the significant share of marine mac-
roalgae-associated heterotrophic bacteria with potential bio-
active properties form a valuable source of pharmaceutical 
applications. Presently, we have isolated 148 heterotrophic 
bacterial species affiliated with 7 different species of marine 
macroalgae belonging to the classes Chlorophyceae, Rhodo-
phyceae, and Pheophyceae including brown algae (Sargas-
sum myricocystum, Padina gymnospora, Turbinaria ornata), 
red algae (Hypnea valentiae. Kappaphycus alvarezii) and 
green algae (Ulva reticulata, Caulerpa racemosa). Major 
share (83%) of the bioactive isolates was the representatives 
of γ-Proteobacteria and Firmicutes. The bacteria selected 
for the current study were found to possess potential antibac-
terial properties against clinically important pathogens (MIC 
6.25-25 µg/mL) E. coli, S. pyogenes, E. tarda, V. parahemo-
lyticus, MRSA, and VRE. The strains were also examined 
for their pathogenic effects on blood agar plates and found to 
be non-pathogenic. It is widely accepted that the pathogenic-
ity of disease-causing microorganisms could be evaluated 
by the production of certain extracellular products, such as 
hemolysins on blood agar plates (Gao et al. 2000).
Previous studies illustrated that the bacterial species 
in symbiotic association with eukaryotic host organisms 
appeared to display significantly greater bioactivities than 
the free-living microorganisms in the ocean and oceanic sed-
iments (Zeng et al. 2005). The sponge-bacterial symbiotic 
Fig. 4  Loading plot diagram (various components namely, PC-1 and 
PC-2 in rotated space) of antioxidant activities vis-a-vis anti-inflam-
matory, anti-diabetic, anti-hypertensive and anti-cholesterol activities 
of different organic extracts of B. amyloliquefaciens MTCC 12716 
and S. algae MTCC 12715. The abbreviations were explained in the 
text
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association has been considered as an important model sys-
tem, and there have been several studies describing marine 
host associated heterotrophs and their potential bioactive 
properties (Quevrain et al. 2014).
It was reported that, among the phylum Firmicutes, Bacil-
lus sp. were dominantly present as heterotrophs with various 
marine macroalgae (Lachnit et al. 2011), and were reported 
for potential antibacterial and antifungal activities (Penesyan 
et al. 2010; Chakraborty et al. 2014). Two of the most active 
cultures B. amyloliquefaciens MTCC 12716 and S. algae 
MTCC 12715 exhibited a broad inhibition spectrum, being 
active against the pathogens including multidrug-resistant 
pathogens, such as MRSA and VRE (MIC 6.25–25 µg/mL). 
Notably, B. amyloliquefaciens MTCC 12716 displayed sig-
nificantly greater antibacterial activity than those exhibited 
by S. algae MTCC 12715. Vancomycin-resistant Entero-
cocci (VRE) and methicillin-resistant Staphylococcus aureus 
(MRSA) were reported to cause nosocomial infections, and 
have been connected with increased rates of illness and 
death (Amalaradjou and Venkitanarayanan 2014). In recent 
times, MRSA is a serious clinical problem attributed to the 
multidrug-resistance against variously available antibiotics. 
Although habitually opportunistic, many S. aureus strains 
are now recognized to be destructively pathogenic. It was 
assessed that Staphylococci permanently inhabit about 25% 
of adults permanently, and 75–80% transiently (Archer et al. 
2011). The emergence of antibiotic-resistant bacteria led us 
to explore the new marine habitats for screening the produc-
tion of novel anti-infective elements (Gram et al. 2010). It 
was found that the bacteria associated with brown alga Sar-
gassum sp. had the antibacterial characteristic with inhibition 
zone ranging 3.6–4.9 mm against MRSA (Susilowati et al. 
2015). Li et al. (2005) described the antibacterial activities 
of the solvent extract of Aspergillus sp., which was associated 
with red marine macroalga Hypnea saiidana, against MRSA. 
Heterotrophic Pseudomonas sp. isolated from Ceratodyction 
spongiosum (red marine macroalga) (Isnansetyo et al. 2001) 
was reported to inhibit the growth of MRSA. Antibacterial 
activity of Bacillus licheniformis in association with inter-
tidal macroalgae Fucus serratus against MRSA and VRE 
were reported previously by Jamal et al. (2006). Thus, vari-
ous studies on macroalgae-associated bacteria proved their 
antimicrobial potential against different pathogenic organ-
isms (Penesyan et al. 2009; Chakraborty et al. 2014).
Marine microorganisms were poorly investigated for 
the development of drug candidates against common life-
style disease targets, but might be of significant potential 
in the quest for new anti-diabetic, anti-inflammatory or 
anti-cholesterol drugs (Debbab et al. 2010). The marine 
macroalgae-associated heterotrophic bacteria B. amylolique-
faciens and S. algae exhibited significant antioxidative 
properties (Table 3). As compared to DPPH assay for deter-
mining antioxidant activity, ABTS assay was found to be 
more prognostic for marine bacterial extracts (Al-Zereini 
2014). The greater ABTS radical quenching activities of 
the organic extracts from these bacteria were observed than 
those recorded in DPPH scavenging properties, could be 
attributed to the statement that ABTS measures antioxidant 
ability of hydrophilic and hydrophobic fractions, whereas 
DPPH calculates antioxidant activity only for the hydro-
phobic antioxidants. Antioxidants were found to reduce or 
terminate the oxidation process of the reductants (oxidizable 
components), through free radical quenching and decreasing 
oxidative stress (disproportionate generation of reactive oxy-
gen species and reactive nitrogen species) (Scott 2004). The 
resultant oxidation of various biomolecules might potentially 
lead to the development of various oxidative stress-induced 
disorders, such as hypertension, type-2 diabetes and arte-
riosclerotic vascular disease (Scott 2004). There has been 
increasing evidence that free radical-induced damage could 
play an important role in the onset of type-2 diabetes and 
impaired glucose tolerance (Wright et al. 2006) along with 
vascular injury and organ dysfunction due to hypertension 
(Elahi and Matata 2006).
B. amyloliquefaciens MTCC 12716 and S. algae MTCC 
12715 showing potential antibacterial activities against clini-
cally important pathogens were selected to evaluate their 
pharmacological properties associated with hypertension, 
inflammation, diabetes and hypercholesterolemia. Notably, 
Angiotensin Converting Enzyme (ACE) inhibitors prevent 
the vasoconstricting octapeptide angiotensin II conversion 
leading to the relaxation of blood vessels resulting in a lower 
blood pressure (Dostal and Baker 1999). ACE inhibitors 
can be the potential pharmacophores for the management 
of hypertensive disorders. However, the adverse reactions 
of synthetic drugs (Atkinson and Robertson 1979) have con-
tributed to a greater interest in searching for natural ACE 
inhibitors. The organic extract of B. amyloliquefaciens 
MTCC 12716 displayed significantly greater ACE inhibitory 
activity  (IC90 448 µg/mL) than that exhibited by S. algae 
 (IC90 663 µg/mL). There were reports that the microbial pep-
tides and secondary metabolites of actinomycetes (Manthey 
and Reuter1989) were potent ACE inhibitors.
The α-amylase and α-glucosidase were reported to 
involve in the catabolism of ingested sugar moieties and 
their inhibition slows down the intake of glucose by acting 
as a promising approach in the treatment of type-2 diabe-
tes (Tabatabaei-Malazy et al. 2015). The organic extract of 
B. amyloliquefaciens MTCC 12716 displayed significantly 
greater α-glucosidase inhibitory activity  (IC90 84 µg/mL) 
than that exhibited by S. algae  (IC90 > 600 µg/mL) and acar-
bose  (IC90 645 µg/mL), the commonly prescribed drug for 
type-2 diabetes. Pandey et al. (2013) found that the marine 
sponge Aka coralliphaga associated heterotrophic Proteo-
bacteria and Firmicutes, developed various glucosidase 
inhibitors.
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The cyclooxygenase isoforms (constitutive COX-1 and 
inducible COX-2) and lipoxygenase (5-LOX) enzymes 
were reported to catalyze the synthesis of inflammatory 
lipid mediators, such as prostaglandins and leukotrienes 
(Charlier and Michaux 2003). Dual 5-LOX/COX-2 inhibi-
tors are prospective anti-inflammatory candidates as they 
function by impeding the development of inflammatory 
prostaglandins and leukotrienes. Such combined inhibi-
tion of 5-LOX/COX-2 avoids the major drawbacks associ-
ated with COX-1 inhibitors and protects the gastrointes-
tinal mucosa (Charlier and Michaux 2003). The organic 
extract of B. amyloliquefaciens MTCC 12716 displayed 
significantly greater COX-2 and 5-LOX inhibitory activi-
ties  (IC90 29 and 6.06 µg/mL, respectively) than those 
exhibited by S. algae  (IC90 44 and 7.73 µg/mL, respec-
tively). Significant anti-inflammatory activities of marine 
symbiotic bacterial crude extracts were reported earlier by 
Kurian et al. (2015).
Hyperlipidemia (elevated cholesterol or triglyceride) 
has been recognized as one of the most important causes 
of atherosclerosis-related disorders, such as coronary heart 
disease and peripheral vascular disease. HMG-CoA reduc-
tase (hMGCR) was found to be the pivotal enzyme in the 
rate determining step of sterol biosynthesis and the statin-
like drugs are inhibitors of human hMGCR (Maciejak et al. 
2013). The organic extract of B. amyloliquefaciens MTCC 
12716 displayed significantly greater hMGCR inhibitory 
activities  (IC90 17 µg/mL, respectively) than that exhibited 
by S. algae  (IC90 75 µg/mL).
The greater proton integral due to saturated hydrocarbons 
(at δH 0.1-2.0) in 1H NMR spectrum of the organic extract of 
S. algae MTCC 12715 were attributed to associate with fatty 
acyl esters or fatty acid derivatives, phospholipids, sterols, 
or glycolipids. The presence of fatty acyl analogs could be 
corroborated by the higher proton integrals of the S. algae 
MTCC 12715 extract (∑H ~ 24) at δH 2-3.5 (attributed to the 
presence of acetyl and -OCH3 groups). Likewise, the higher 
proton integrals attributed to the acetyl or allylic functionali-
ties (∑H > 60) in the extract prepared from S. algae MTCC 
12715, and comparatively weaker proton integrals at this 
position for B. amyloliquefaciens MTCC 12716 extract 
(∑H < 50) appropriately supported these assignments. The 
greater proton integrals of the S. algae MTCC 12715 organic 
extract, at the characteristic olefinic region (δH 4.5–6) could 
thus be correlated with the occurrences of fatty acid deriva-
tives with mono- and/or poly-unsaturations. Since the fatty 
acid derivatives were considered as the structural compo-
nents of the organisms and did not attribute to the bioac-
tive potential, the greater pharmacological properties of the 
EtOAc extract of B. amyloliquefaciens MTCC 12716 could 
thus be rationalized. Bioactive polysaccharides were found 
to occupy a predominant role in determining the pharmaco-
logical properties of the microorganisms (Rehm 2010), and 
greater proton integrals (∑H ~ 65) at the anomeric region of 
the 1H NMR spectrum (δH 3.6–4.5) of the EtOAc extract of 
B. amyloliquefaciens MTCC 12716, than that obtained from 
S. algae MTCC 12715 extract (∑H < 50) attributed to the 
possible functional role of polysaccharide analogs in deter-
mining the bioactive properties of the former. The greater 
1H NMR proton integral (∑H ~ 29) due to the aryl signals 
(δH 6.6–8.6), in the solvent extracts of B. amyloliquefaciens 
MTCC 12716 might be associated with the presence of aro-
matic centers, which were found to possess a significant role 
in determining the pharmacological properties of the said 
bacterium.
In this study, the organic extract of B. amyloliquefa-
ciens MTCC 12716 was found to possess greater number of 
electronegative carbonyl and aryl carbons in the downfield 
space of the 13C NMR spectrum (δC 180–200 and 140–160, 
respectively) than that prepared from S. algae MTCC 12715, 
which apparently signified the presence of electron-rich cen-
tered bioactive principles of the former. The EtOAc extract 
of S. algae and B. amyloliquefaciens exhibited 13C NMR 
olefinic functionalities at the characteristic region of δC 
110–140, although lower proton integrals in the 1H NMR 
spectrum of the latter assigned to the occurrences of quater-
nary olefinic carbons. The signal intensity and the number 
of 13C carbon atoms due to the alkoxy (δC 45–70) carbon 
and those associated with alkyl alkanoate groups (δC 75–80) 
were lesser in the organic extract of B. amyloliquefaciens 
MTCC 12716 than that from S. algae MTCC 12715. These 
results appropriately corroborated the presence of fatty acyl 
analogs (along with phospholipids), which were reported as 
the structural components of the bacterium, and possessed 
meager functional role towards the bioactivities and phar-
macological properties, due to the S. algae MTCC 12715 
extract.
Marine Bacillus species was reported to produce prom-
ising bioactive metabolites, such as aromatic polyketides 
(with multiple carbonyl groups bearing aromatic func-
tionalities), bacteriocins, and other unique compounds of 
potential clinical significance (Armstrong et al. 2001). 
In this study, PCA were performed on the basis of the 
covariance structure of the data, which convert the means 
across the originally measured numerical information into 
new variables, the principal components (PCs), which 
were orthogonal (Maisuthisakul et al. 2008). PCA appro-
priately corroborated the antioxidant vis-a-vis enzyme 
inhibitory activities contributing to the various phar-
maceutical potential of the studied marine macroalgae-
associated symbionts, and revealed the loadings of PC1 
and PC2 for the studied bioactivities. The organic extract 
of B. amyloliquefaciens displayed significantly greater 
antioxidative properties  (IC90 < 1 mg/mL) and the activi-
ties showed considerable positive correlation (r2 > 0.8, 
P < 0.05) with the inhibitory activities against ACE-1, 
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pro-inflammatory biocatalysts, DPP-4 and hMGCR, 
which were associated with hypertension, inflammation, 
diabetes, and hypercholesterolemia, respectively. Spe-
cifically, the loadings of PC1 were also inclined towards 
the positive correlation between the bioactivities, which 
implied that the functional groups present in the extract 
prepared from B. amyloliquefaciens MTCC 12716 were 
endowed with the potential pharmacological properties 
with regard to antioxidant (DPPH scavenging), anti-
inflammatory (anti-cyclooxygenase), anti-diabetic (DPP-4 
inhibitory), and anti-hypercholesterolemic (hMGCR 
inhibitory) activities. These results appropriately revealed 
the promising therapeutic potential of marine macroalga-
associated heterotrophic bacterium B. amyloliquefaciens 
MTCC 12716.
The present work revealed pharmaceutical potentials 
of the organic extracts derived from the heterotrophic 
bacteria in association with marine macroalgae. The het-
erotrophs predominantly belonging to γ-Proteobacteria 
and Firmicutes comprised greater than 50% of culturable 
bacteria, and were found to possess potential antibacte-
rial properties (MIC 6.25–25 µg/mL) against the clinically 
important pathogens including MRSA and VRE. Hetero-
trophic B. amyloliquefaciens MTCC 12716 and S. algae 
MTCC 12715 displayed potential anti-infective proper-
ties and their ethyl acetate extracts were assayed for their 
pharmacological properties using various in vitro models. 
The organic extract of B. amyloliquefaciens MTCC 12716 
displayed significantly greater ACE-1, pro-inflammatory 
COX-2/5-LOX, α glucosidase/DPP-4 and hMGCR-inhibi-
tory activities associated with hypertension, inflammation, 
diabetes, and hypercholesterolemia, respectively. 1H NMR 
fingerprint analyses of the prominent functional groups 
in the organicextracts of the symbionts revealed the pres-
ence of greater proton integral of the same derived from B. 
amyloliquefaciens MTCC 12716 at the downfield region 
of δH 2.0-3.5 and 4.5–8.5, which could be responsible 
for the potential bioactivities. The heterotrophic marine 
macroalgae-associated B. amyloliquefaciens MTCC 12716 
might, therefore, serve as a potential therapeutic candidate 
to develop microbial products with wide pharmaceutical 
and biotechnological applications.
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